Iodine kinetic studies during amiodarone treatment

Area of Science:

• Endocrinology
• Pharmacology
• Thyroid Research

Background:

• Amiodarone is an antiarrhythmic drug with a high iodine content.
• The biological impact of amiodarone's iodine load on thyroid kinetics is not fully understood.

Purpose of the Study:

• To investigate the iodine kinetics in patients treated with amiodarone.
• To assess the biological significance of amiodarone's iodine content on thyroid function and hormone levels.

Main Methods:

• Serial iodine kinetic studies were conducted in 15 patients over 6 months of amiodarone therapy (300 mg/day).
• Measurements included urinary inorganic iodide excretion, thyroid iodide clearance, plasma inorganic iodide, and absolute thyroid iodide uptake.
• Plasma thyroid hormone levels (T4, free T4, T3, rT3) were monitored.

Main Results:

• Urinary iodide excretion increased dramatically, while thyroid iodide clearance decreased significantly.
• Plasma inorganic iodide levels rose substantially, and absolute thyroid iodide uptake initially increased then declined but remained elevated.
• Patients exhibited characteristic thyroid hormone changes (increased T4, free T4, rT3; decreased T3) while remaining clinically euthyroid.

Conclusions:

• Amiodarone treatment leads to a massive increase in available inorganic iodide.
• This iodine overload is a likely cause of amiodarone-induced hypothyroidism and thyrotoxicosis.
• Understanding these kinetics is crucial for managing patients on amiodarone therapy.